Native arteriovenous fistula (AVF) is the favorite access for hemodialysis (HD). The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) recommends its creation in most patents with renal failure. Unfortunately, intensive efforts to promote native AVF in patents with marginal vessels have increased the rate of primary fistula failure. A non-functioning fistula prompts the use of central venous catheter (CVC) that, unlike AVF, has been associated with an increased risk of morbidity and mortality among patents receiving HD. We believe that successful and timely AVF placement relies on the development of a multidisciplinary integrated preoperative program divided into five stages: (i) management of patents with advanced chronic kidney disease (CKD), (ii) management of preoperative risk factors for AVF failure, (iii) planning of native AVF, (iv) assessment of patent eligibility and (v) preoperative vascular mapping. Focusing specifically on native AVF, we review scientific evidence regarding preoperative management of this vascular access in order to favor construction of long-term functioning fistula minimizing development of severe complications.
BresciaM.J., CiminoJ.E., AppelK., HurwichB.J.Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula.N Engl J Med.1966; 275(20): 1089–1092.
2.
KonnerK.History of vascular access for haemodialysis.Nephrol Dial Transplant.2005; 20(12): 2629–2635.
3.
WoodsJ.D., TurenneM.N., StrawdermanR.L.. Vascular access survival among incident hemodialysis patents in the United States.Am J Kidney Dis.1997; 30(1): 50–57.
4.
AstorB.C., EustaceJ.A., PoweN.R., KlagM.J., FinkN.E., CoreshJ.CHOICE Study. Type of vascular access and survival among incident hemodialysis patents: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.J Am Soc Nephrol.2005; 16(5): 1449–1455.
5.
DhingraR.K., YoungE.W., Hulbert-ShearonT.E., LeaveyS.F., PortF.K.Type of vascular access and mortality in U.S. hemodialysis patents.Kidney Int.2001; 60(4): 1443–1451.
6.
ChurchillD.N., BlakeP.G., JindalK.K., ToffelmireE.B., GoldsteinM.B.Canadian Society of Nephrology. Clinical practice guidelines for initiation of dialysis.J Am Soc Nephrol.1999; 10(Suppl 13): S289–S291.
7.
HoenB., Paul-DauphinA., HestinD., KesslerM.EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patents.J Am Soc Nephrol.1998; 9(5): 869–876.
8.
MannsB., TonelliM., YilmazS.. Establishment and maintenance of vascular access in incident hemodialysis patents: a prospective cost analysis.J Am Soc Nephrol.2005; 16(1): 201–209.
9.
National Kidney Foundation-Dialysis Outcomes Quality Initiative.NKF-DOQI clinical practice guidelines for vascular access.Am J Kidney Dis.1997; 30(4)(Suppl 3): S150–S191.
10.
United States Renal Data System.2016 USRDS annual data report: Epidemiology of kidney disease in the United States.National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016. Available from: https://www.usrds.org/adr.aspx.
11.
PisoniR.L., YoungE.W., DykstraD.M.. Vascular access use in Europe and the United States: results from the DOPPS.Kidney Int.2002; 61(1): 305–316.
12.
RostandS.G., GretesJ.C., KirkK.A., RutskyE.A., AndreoliT.E.Ischemic heart disease in patents with uremia undergoing maintenance hemodialysis.Kidney Int.1979; 16(5): 600–611.
13.
ThomasM.C., CooperM.E., ZimmetP.Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease.Nat Rev Nephrol.2016; 12(2): 73–81.
14.
Al-JaishiA.A., LiuA.R., LokC.E.. Complications of the arteriovenous fistula: a systematic review.J Am Soc Nephrol.2017; 28(6): 1839–1850.
15.
Al-JaishiA.A., OliverM.J., ThomasS.M.. Patency rates of the arteriovenous fistula for hemodialysis: a systematic review and meta-analysis.Am J Kidney Dis.2014; 63(3): 464–478.
16.
SchinstockC.A., AlbrightR.C., WilliamsA.W.. Outcomes of arteriovenous fistula creation after the fistula first initiative.Clin J Am Soc Nephrol.2011; 6(8): 1996–2002.
17.
Consensus Development Conference Panel.Morbidity and mortality of renal dialysis: an NIH consensus conference statement.Ann Intern Med.1994; 121(1): 62–70.
18.
EadingtonD.W.Delayed Referral for Dialysis: Higher Morbidity and Higher Costs.Semin Dial.1995; 8(5): 258–260.
19.
InnesA., RoweP.A., BurdenR.P.. Early deaths on renal replacement therapy: the need for early nephrological referral.Nephrol Dial Transplant.1992; 7(6): 467–471.
20.
KimD.H., KimM., KimH.. Early referral to a nephrologist improved patent survival: prospective cohort study for end-stage renal disease in Korea.PLoS ONE.2013; 8(1): e55323.
21.
GonçalvesE.A.P., AndreoliM.C.C., WatanabeR.. Effect of temporary catheter and late referral on hospitalization and mortality during the first year of hemodialysis treatment.Artif Organs.2004; 28(11): 1043–1049.
22.
GøranssonL.G., BergremH.Consequences of late referral of patents with end-stage renal disease.J Intern Med.2001; 250(2): 154–159.
23.
CaskeyF.J., WordsworthS., BenT.. Early referral and planned initiation of dialysis: what impact on quality of life?Nephrol Dial Transplant.2003; 18(7): 1330–1338.
24.
BonucchiD., D'AmelioA., GrosoliM.. Vascular access for haemodialysis: from surgical procedure to an integrated therapeutic approach.Nephrol Dial Transplant.1998; 13(Suppl 7): 78–81.
25.
GomesA., SchmidtR., WishJ.Re-envisioning Fistula First in a patent-centered culture.Clin J Am Soc Nephrol.2013; 8(10): 1791–1797.
26.
Clinical Practice Guidelines for Vascular Access.Clinical Practice Guidelines for Vascular Access.Am J Kidney Dis.2006; 48: S176–S247.
27.
McGillR.L., TsukaharaT., BhardwajR., KapetanosA.T., MarcusR.J.Inpatient venous access practices: PICC culture and the kidney patent.J Vasc Access.2015; 16(3): 206–210.
28.
ChopraV., AnandS., HicknerA.. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis.Lancet.2013; 382(9889): 311–325.
29.
GreeneM.T., FlandersS.A., WollerS.C., BernsteinS.J., ChopraV.The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities.Am J Med.2015; 128(9): 986–93.e1.
30.
DrewD.A., WeinerD.E.Peripherally Inserted Central Catheters (PICCs) in CKD: PICCing the Best Access for Kidney Disease Patents.Am J Kidney Dis.2016; 67(5): 724–727.
31.
El TersM., SchearsG.J., TalerS.J.. Association between prior peripherally inserted central catheters and lack of functioning arteriovenous fistulas: a case-control study in hemo-dialysis patents.Am J Kidney Dis.2012; 60(4): 601–608.
32.
McGillR.L., RuthazerR., MeyerK.B., MiskulinD.C., WeinerD.E.Peripherally Inserted Central Catheters and Hemodialysis Outcomes.Clin J Am Soc Nephrol.2016; 11(8): 1434–1440.
33.
ChopraV., FlandersS.A., SaintS.. The Michigan Appropriateness Guide for Intravenous Catheters (MAGIC): Results From a Multispecialty Panel Using the RAND/UCLA Appropriateness Method.Ann Intern Med.2015; 163(6 Suppl): S1–40.
34.
AbecassisM., BartlettS.T., CollinsA.J.. Kidney transplantation as primary therapy for end-stage renal disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) Conference.Clin J Am Soc Nephrol.2008; 3(2): 471–480.
35.
LiemY.S., WeimarW.Early living-donor kidney transplantation: a review of the associated survival benefit.Transplantation.2009; 87(3): 317–318.
36.
Meier-KriescheH.U., PortF.K., OjoA.O.. Effect of waiting time on renal transplant outcome.Kidney Int.2000; 58(3): 1311–1317.
37.
YeatesK., ZhuN., VoneshE.. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada.Nephrol Dial Transplant.2012; 27(9): 3568–3575.
38.
WeinhandlE.D., FoleyR.N., GilbertsonD.T., ArnesonT.J., SnyderJ.J., CollinsA.J.Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patents.J Am Soc Nephrol.2010; 21(3): 499–506.
39.
RemuzziA., BozzettoM., BrambillaP.Is shear stress the key factor for AVF maturation?J Vasc Access.2017; 18(Suppl. 1): 10–14.
40.
AllonM., GreeneT., DemberL.M.. Hemodialysis Fistula Maturation Study Group. Association between Preoperative Vascular Function and Postoperative Arteriovenous Fistula Development.J Am Soc Nephrol.2016; 27(12): 3788–3795.
41.
Vazquez-PadronR.I., AllonM.New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.Clin J Am Soc Nephrol.2016; 11(8): 1495–1503.
42.
ShiuY-T, LitovskyS.H., CheungA.K.. Preoperative Vascular Medial Fibrosis and Arteriovenous Fistula Development.Clin J Am Soc Nephrol.2016; 11(9): 1615–1623.
43.
FarberA., ImreyP.B., HuberT.S.. HFM Study Group. Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study.J Vasc Surg.2016; 63(1): 163–70.e6.
44.
PetersonW.J., BarkerJ., AllonM.Disparities in fistula maturation persist despite preoperative vascular mapping.Clin J Am Soc Nephrol.2008; 3(2): 437–441.
45.
MillerP.E., TolwaniA., LuscyC.P.. Predictors of adequacy of arteriovenous fistulas in hemodialysis patents.Kidney Int.1999; 56(1): 275–280.
46.
LokC.E., AllonM., MoistL., OliverM.J., ShahH., ZimmermanD.Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).J Am Soc Nephrol.2006; 17(11): 3204–3212.
47.
ErnandezT., SaudanP., BerneyT., MerminodT., BednarkiewiczM., MartinP.Y.Risk factors for early failure of native arteriovenous fistulas.Nephron Clin Pract.2005; 101(1): c39–c44.
48.
Monroy-CuadrosM., YilmazS., Salazar-BañuelosA.. Risk factors associated with patency loss of hemodialysis vascular access within 6 months.Clin J Am Soc Nephrol.2010; 5(10): 1787–1792.
49.
PremuzicV., HudolinT., PasiniJ.. Hypoproteinemia as a prognostic risk factor for arteriovenous fistula failure.Hemodial Int.2017 Jan 29. doi: 10.1111/hdi.12538. [Epub ahead of print].
50.
KatsM., HawxbyA.M., BarkerJ., AllonM.Impact of obesity on arteriovenous fistula outcomes in dialysis patents.Kidney Int.2007; 71(1): 39–43.
51.
LauvaoL.S., IhnatD.M., GoshimaK.R., ChavezL., GruessnerA.C., MillsJLSr. Vein diameter is the major predictor of fistula maturation.J Vasc Surg.2009; 49(6): 1499–1504.
52.
DemberL.M., ImreyP.B., BeckG.J.. Hemodialysis Fistula Maturation Study Group. Objectives and design of the hemodialysis fistula maturation study.Am J Kidney Dis.2014; 63(1): 104–112.
53.
KnollG.A., WellsP.S., YoungD.. Thrombophilia and the risk for hemodialysis vascular access thrombosis.J Am Soc Nephrol.2005; 16(4): 1108–1114.
54.
SalmelaB., HartmanJ., PeltonenS.. Thrombophilia and arteriovenous fistula survival in ESRD.Clin J Am Soc Nephrol.2013; 8(6): 962–968.
55.
DemberL.M., BeckG.J., AllonM.. Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.JAMA.2008; 299(18): 2164–2171.
56.
PisoniR., Barker-FinkelJ., AlloM.Statin therapy is not associated with improved vascular access outcomes.Clin J Am Soc Nephrol.2010; 5(8): 1447–1450.
57.
IrishA.B., ViecelliA.K., HawleyC.M.. Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group. Effect of fish oil supplementation and aspirin use on arteriovenous fistula failure in patients requiring hemodialysis: a randomized clinical trial.JAMA Intern Med.2017; 177(2): 184–193.
58.
KeskarV., SoodM.M.Use of oral anticoagulation in the management of atrial fibrillation in patients with ESRD: Con.Clin J Am Soc Nephrol.2016; 11(11): 2085–2092.
59.
NigwekarS.U., BlochD.B., NazarianR.M.. Vitamin K-dependent carboxylation of matrix gla protein influences the risk of calciphylaxis.J Am Soc Nephrol.2017; 28(6): 1717–1722.
60.
EthierJ., MendelssohnD.C., ElderS.J.. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study.Nephrol Dial Transplant.2008; 23(10): 3219–3226.
61.
JindalK., ChanC.T., DezielC.. Canadian Society of Nephrology Committee for Clinical Practice Guidelines. Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.J Am Soc Nephrol.2006; 17(3)(Suppl 1): S1–S27.
SezerS., OzdemirF.N., AratZ., TuranM., HaberalM.Triad of malnutrition, inflammation, and atherosclerosis in hemodialysis patients.Nephron.2002; 91(3): 456–462.
67.
KokuboT., IshikawaN., UchidaH.. CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas.J Am Soc Nephrol.2009; 20(6): 1236–1245.
68.
BoltonC.H., DownsL.G., VictoryJ.G.. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.Nephrol Dial Transplant.2001; 16(6): 1189–1197.
69.
SutliffR.L., WalpE.R., El-AliA.M.. Effect of medial calcification on vascular function in uremia. See comment in PubMed Commons below.Am J Physiol Renal Physiol.2011; 301(1): F78–83.
70.
AmannK.Media calcification and intima calcification are distinct entities in chronic kidney disease.Clin J Am Soc Nephrol.2008; 3(6): 1599–1605.
71.
Roy-ChaudhuryP., SukhatmeV.P., CheungA.K.Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint.J Am Soc Nephrol.2006; 17(4): 1112–1127.
HodT., PatibandlaB.K., VinY., BrownR.S., Goldfarb-RumyantzevA.S.Arteriovenous fistula placement in the elderly: when is the optimal time?J Am Soc Nephrol.2015; 26(2): 448–456.
75.
LeeT., ThamerM., ZhangQ., ZhangY., AllonM.Reduced Cardiovascular Mortality Associated with Early Vascular Access Placement in Elderly Patients with Chronic Kidney Disease.Am J Nephrol.2016; 43(5): 334–340.
76.
OlshaO., HijaziJ., GoldinI., ShemeshD.Vascular access in hemodialysis patients older than 80 years.J Vasc Surg.2015; 61(1): 177–183.
77.
LokC.E., OliverM.J., SuJ., BholaC., HanniganN., JassalS.V.Arteriovenous fistula outcomes in the era of the elderly dialysis population.Kidney Int.2005; 67(6): 2462–2469.
78.
SwindlehurstN., SwindlehurstA., LumgairH.. Vascular access for hemodialysis in the elderly.J Vasc Surg.2011; 53(4): 1039–1043.
CaiQ-Z, LuX-Z, LuY., WangA.Y.Longitudinal changes of cardiac structure and function in CKD (CASCADE study).J Am Soc Nephrol.2014; 25(7): 1599–1608.
81.
CheungA.K., SarnakM.J., YanG.. HEMO Study Group. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study.Kidney Int.2004; 65(6): 2380–2389.
82.
RaoN.N., DundonB.K., WorthleyMl, FaullR.J.The Impact of Arteriovenous Fistulae for Hemodialysis on the Cardiovascular System.Semin Dial.2016; 29(3): 214–221.
83.
IwashimaY., HorioT., TakamiY.. Effects of the creation of arteriovenous fistula for hemodialysis on cardiac function and natriuretic peptide levels in CRF.Am J Kidney Dis.2002; 40(5): 974–982.
84.
DundonB.K., TorpeyK., NelsonA.J.. The deleterious effects of arteriovenous fistula-creation on the cardiovascular system: a longitudinal magnetic resonance imaging study.Int J Nephrol Renovasc Dis.2014; 7: 337–345.
85.
KorsheedS., EldehniM.T., JohnS.G.. Effects of arteriovenous fistula formation on arterial stiffness and cardiovascular performance and function.Nephrol Dial Transplant.2011; 26(10): 3296–3302.
86.
GuytonA.C., SagawaK.Compensations of cardiac output and other circulatory functions in areflex dogs with large A-V fistulas.Am J Physiol.1961; 200: 1157–1163.
87.
MacRaeJ.M., PandeyaS., HumenD.P.. Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms.Am J Kidney Dis.2004; 43(5): e17–e22.
88.
EngelbertsI., TordoirJ.H., BoonE.S., SchreijG.High-output cardiac failure due to excessive shunting in a hemodialysis access fistula: an easily overlooked diagnosis.Am J Nephrol.1995; 15(4): 323–326.
89.
BeginV., EthierJ., DumontM., LeblancM.Prospective evaluation of the intra-access flow of recently created native arteriovenous fistulae.Am J Kidney Dis.2002; 40(6): 1277–1282.
BasileC., LomonteC., VernaglioneL.. The relationship between the flow of arteriovenous fistula and cardiac output in haemodialysis patients.Nephrol Dial Transplant.2008; 23(1): 282–287.
92.
KristensenS.D., KnuutiJ., SarasteA.. Authors/Task Force Members. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).Eur Heart J.2014; 35(35): 2383–2431.
ReddyY.N.V., MelenovskyV., RedfieldM.M., NishimuraR.A., BorlaugB.A.High-Output Heart Failure: A 15-Year Experience.J Am Coll Cardiol.2016; 68(5): 473–482.
95.
AmerlingR., MalostovkerI., DubrowA., RoseroH., HavesonS.Access High output heart failure in patients with upper arm A-V fistulae: Diagnosis and treatment.Hemodial Int.2005; 9(1): 70–71.
96.
BeigiA.A., SadeghiA.M.M., KhosraviA.R., KaramiM., MasoudpourH.Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure.J Vasc Access.2009; 10(3): 160–166.
97.
NakamuraT., SuemitsuK., NakamuraJ.Superficialization of brachial artery as effective alternative vascular access.J Vasc Surg.2014; 59(5): 1385–1392.
98.
MurakamiM., SakaguchiG., MoriN.Arteriovenous fistula combined with brachial artery superficialization is effective in patients with a high risk of maturation failure.J Vasc Surg.2017; 65(2): 452–458.
99.
NolanM.E., YadavH., CawcuttK.A., Cartin-CebaR.Complication rates among peripherally inserted central venous catheters and centrally inserted central catheters in the medical intensive care unit.J Crit Care.2016; 31(1): 238–242.
LucianiA., ClementO., HalimiP.. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US.Radiology.2001; 220(3): 655–660.
102.
RozmusG., DaubertJ.P., HuangD.T., RoseroS., HallB., FrancisC.Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.J Interv Card Electrophysiol.2005; 13(1): 9–19.
103.
SpittellP.C., HayesD.L.Venous complications after insertion of a transvenous pacemaker.Mayo Clin Proc.1992; 67(3): 258–265.
104.
GonsalvesC.F., EschelmanD.J., SullivanK.L., DuBoisN., BonnJ.Incidence of central vein stenosis and occlusion following upper extremity PICC and port placement.Cardiovasc Intervent Radiol.2003; 26(2): 123–127.
OttenT.R., SteinP.D., PatelK.C., MustafaS., SilbergleitA.Thromboembolic disease involving the superior vena cava and brachiocephalic veins.Chest.2003; 123(3): 809–812.
107.
BambauerR., InnigerR., PirrungK.J., SchielR., DahlemR.Complications and side effects associated with large-bore catheters in the subclavian and internal jugular veins.Artif Organs.1994; 18(4): 318–321.
108.
BarrettN., SpencerS., McIvorJ.. Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol. Dial.Transplant.1988; 3(4): 423–425.
109.
CimochowskiG.E., WorleyE., RutherfordW.E., SartainJ., BlondinJ., HarterH.Superiority of the internal jugular over the subclavian access for temporary dialysis.Nephron.1990; 54(2): 154–161.
110.
HernándezD., DíazF., SuriaS.. Subclavian catheter-related infection is a major risk factor for the late development of subclavian vein stenosis.Nephrol Dial Transplant.1993; 8(3): 227–230.
111.
KumarD.R., HanlinE., GlurichI., MazzaJ.J., YaleS.H.Virchows contribution to the understanding of thrombosis and cellular biology.Clin Med Res.2010; 8(3–4): 168–172.
112.
FurieB., FurieB.C.Mechanisms of thrombus formation.N Engl J Med.2008; 359(9): 938–949.
113.
BodeA.S., PlankenR.N., MerkxM.A.. Feasibility of non-contrast-enhanced magnetic resonance angiography for imaging upper extremity vasculature prior to vascular access creation.Eur J Vasc Endovasc Surg.2012; 43(1): 88–94.
114.
DavenportM.S., KhalatbariS., CohanR.H., DillmanJ.R., MylesJ.D., EllisJ.H.Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.Radiology.2013; 268(3): 719–728.
115.
AsifA., CherlaG., MerrillD.. Venous mapping using venography and the risk of radiocontrast-induced nephropathy.Semin Dial.2005; 18(3): 239–242.
116.
WonY.D., LeeJ.Y., ShinY.S.. Small dose contrast venography as venous mapping in predialysis patients.J Vasc Access.2010; 11(2): 122–127.
117.
KianK., WyattC., SchonD., PackerJ., VassalottiJ., MishlerR.Safety of low-dose radiocontrast for interventional AV fistula salvage in stage 4 chronic kidney disease patients.Kidney Int.2006; 69(8): 1444–1449.
118.
QuinnS.F., SchumanE.S., DemlowT.A.. Percutaneous transluminal angioplasty versus endovascular stent placement in the treatment of venous stenoses in patients undergoing hemodialysis: intermediate results.J Vasc Interv Radiol.1995; 6(6): 851–855.
119.
KunduS.Central venous disease in hemodialysis patients: prevalence, etiology and treatment.J Vase Access.2010; 11(1): 1–7.
120.
BakkenA.M., ProtackC.D., SaadW.E., LeeD.E., WaldmanD.L., DaviesM.G.Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.J Vasc Surg.2007; 45(4): 776–783.
AgarwalA.K., HaddadN.J., KhabiriH.How should symptomatic central vein stenosis be managed in hemodialysis patients?Semin Dial.2014; 27(3): 278–281.
123.
AgarwalA.K.Endovascular interventions for central vein stenosis.Kidney Res Clin Pract.2015; 34(4): 228–32.
124.
LevitR.D., CohenR.M., KwakA.. Asymptomatic central venous stenosis in hemodialysis patients.Radiology.2006; 238(3): 1051–1056.
125.
KearonC., AklE.A., ComerotaA.J.. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest.2012; 141(2 Suppl): e419S–e496S.
126.
LanciegoC., RodriguezM., RodriguezA., CarbonellM.A., GarcíaL.G.Permanent pacemaker-induced superior vena cava syndrome: successful treatment by endovascular stent.Cardiovasc Intervent Radiol.2003; 26(6): 576–579.
127.
TeoN., SabharwalT., RowlandE., CurryP., AdamA.Treatment of superior vena cava obstruction secondary to pacemaker wires with balloon venoplasty and insertion of metallic stents.Eur Heart J.2002; 23(18): 1465–1470.
128.
Al ShakarchiJ., HoustonG., InstonN.Early cannulation grafts for haemodialysis: a systematic review.J Vasc Access.2015; 16(6): 493–497.
129.
TordoirJ.H.M., DammersR., van der SandeF.M.Upper extremity ischemia and hemodialysis vascular access.Eur J Vasc Endovasc Surg.2004; 27(1): 1–5.
130.
ZamaniP., KaufmanJ., KinlayS.Ischemic steal syndrome following arm arteriovenous fistula for hemodialysis.Vasc Med.2009; 14(4): 371–376.
131.
YevzlinA.S., ChanM.R., AsifA.Hand Ischemia in a Patient With an Arteriovenous Fistula.Am J Kidney Dis.2016; 67(3): 512–515.
132.
KwunK.B., SchanzerH., FinklerN., HaimovM., BurrowsL.Hemodynamic Evaluation of Angioaccess Procedures for Hemodialysis.Vasc Endovascular Surg.1979; 13(3): 170–177.
133.
YuQ., YuH., ChenS., WangL., YuanW.Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: a single-center study.J Nephrol.2011; 24(5): 597–603.
134.
KeuterX.H.A., KesselsA.G.H., de HaanM.H., van der SandeF.M., TordoirJ.H.Prospective evaluation of ischemia in brachial-basilic and forearm prosthetic arteriovenous fistulas for hemodialysis.Eur J Vasc Endovasc Surg.2008; 35(5): 619–624.
135.
MalikJ., TukaV., KasalovaZ.. Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies.J Vasc Access.2008; 9(3): 155–166.
136.
HuberT.S., LariveB., ImreyP.B.. HFM Study Group. Access-related hand ischemia and the Hemodialysis Fistula Maturation Study.J Vasc Surg.2016; 64(4): 1050–1058.e1.
137.
LeonC., AsifA.Arteriovenous access and hand pain: the distal hypoperfusion ischemic syndrome.Clin J Am Soc Nephrol.2007; 2(1): 175–183.
KudlatyE.A., KendrickD.E., AllemangM.T., KashyapV.S., WongV.L.Upper extremity steal syndrome is associated with atherosclerotic burden and access configuration.Ann Vasc Surg.2016; 35: 82–87.
140.
RochaA., SilvaF., QueirósJ.. Predictors of steal syndrome in hemodialysis patients.Hemodial Int.2012; 16(4): 539–44.
141.
YuS.H., CookP.R., CantyT.G., McGinnR.F., TaftP.M., HyeR.J.Hemodialysis-related steal syndrome: predictive factors and response to treatment with the distal revascularization-interval ligation procedure.Ann Vasc Surg.2008; 22(2): 210–214.
142.
MorsyA.H., KulbaskiM., ChenC., IsiklarH., LumsdenA.B.Incidence and characteristics of patients with hand ischemia after a hemodialysis access procedure.J Surg Res.1998; 74(1): 8–10.
143.
MasciaS., SpieziaS., AssantiA.. Ischemic steal syndrome in a hemodialysis patient: The roles of Doppler ultrasonography and dynamic Doppler studies in diagnosis and treatment selection.J Ultrasound.2010; 13(3): 104–106.
144.
KamperL., FrahnertM., GrebeS-O, HaageP.Radiological assessment of vascular access in haemodialysis patients.J Vasc Access.2014; 15(Suppl 7): S33–S37.
145.
AgrifoglioM., DaineseL., PasottiS.. Preoperative assessment of the radial artery for coronary artery bypass grafting: is the clinical Allen test adequate?Ann Thorac Surg.2005; 79(2): 570–572.
146.
JarvisM.A., JarvisC.L., JonesP.R., SpytT.J.Reliability of Aliens test in selection of patients for radial artery harvest.Ann Thorac Surg.2000; 70(4): 1362–1365.
147.
FuhrmanT.M., PippinW.D., TalmageL.A., ReilleyT.E.Evaluation of collateral circulation of the hand.J Clin Monit.1992; 8(1): 28–32.
148.
Abu-OmarY., MussaS., AnastasiadisK., SteelS., HandsL., TaggartD.P.Duplex ultrasonography predicts safety of radial artery harvest in the presence of an abnormal Allen test.Ann Thorac Surg.2004; 77(1): 116–119.
149.
StarnesS.L., WolkS.W., LampmanR.M.. Noninvasive evaluation of hand circulation before radial artery harvest for coronary artery bypass grafting.J Thorac Cardiovasc Surg.1999; 117(2): 261–266.
WilsonS.E., ed. Vascular access: principles and practice.PA: Lippincott Williams & Wilkins2010; 1–328.
152.
GoffC.D., SatoD.T., BlochP.H.. Steal syndrome complicating hemodialysis access procedures: can it be predicted?Ann Vasc Surg.2000; 14(2): 138–144.
153.
PapasavasP.K., ReifsnyderT., BirdasT.J., CaushajP.F., LeersS.Prediction of arteriovenous access steal syndrome utilizing digital pressure measurements.Vasc Endovascular Surg.2003; 37(3): 179–184.
154.
JenningsW.C., BrownR.E., RuizC.Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome.J Vasc Surg.2011; 54(2): 554–558.
155.
MatoussevitchV., KonnerK., GawendaM.. A modified approach of proximalization of arterial inflow technique for hand ischemia in patients with matured basilic and cephalic veins.Eur J Vasc Endovasc Surg.2014; 48(4): 472–476.
156.
JenningsW., BrownR., BlebeaJ., TaubmanK., MessinerR.Prevention of vascular access hand ischemia using the axillary artery as inflow.J Vasc Surg.2013; 58(5): 1305–1309.
157.
ZanowJ., KrugerU., ScholzH.Proximalization of the arterial inflow: a new technique to treat access-related ischemia.J Vasc Surg.2006; 43(6): 1216–1221, discussion 1221.
158.
ShenoyS., DarcyM.Ultrasound as a tool for preoperative planning, monitoring, and interventions in dialysis arteriovenous access.AJR Am J Roentgenol.2013; 201(4): W539–43.
159.
NiyyarV.D., WasseH.Vascular mapping: does it help to maximize fistulae placement?Adv Chronic Kidney Dis.2009; 16(5): 316–320.
160.
SilvaM.B.Jr., HobsonRWII, PappasP.J.. A strategy for increasing use of autogenous hemodialysis access procedures: impact of preoperative noninvasive evaluation.J Vasc Surg.1998; 27(2): 302–307, discussion 307–308.
161.
LockhartM.E., RobbinM.L., AllonM.Preoperative sonographic radial artery evaluation and correlation with subsequent radiocephalic fistula outcome.J Ultrasound Med.2004; 23(2): 161–168; quiz 169–171.
162.
MalovrhM.The role of sonography in the planning of arteriovenous fistulas for hemodialysis.Semin Dial.2003; 16(4): 299–303.
PatelM.C., BermanL.H., MossH.A., McPhersonS.J.Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion.Radiology.1999; 211(2): 579–583.
165.
KöksoyC., KuzuA., ErdenI., TürkçaparA.G., DüzgünI., AnadolE.Predictive value of colour Doppler ultrasonography in detecting failure of vascular access grafts.Br J Surg.1995; 82(1): 50–52.
166.
AllonM., LockhartM.E., LillyR.Z.. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients.Kidney Int.2001; 60(5): 2013–2020.
167.
SmithG.E., BarnesR., ChetterI.C.Randomized clinical trial of selective versus routine preoperative duplex ultrasound imaging before arteriovenous fistula surgery.Br J Surg.2014; 101(5): 469–474.
168.
MihmanliI., BesirliK., KurugogluS.. Cephalic vein and hemodialysis fistula: surgeons observation versus color Doppler ultrasonographic findings.J Ultrasound Med.2001; 20(3): 217–222.
169.
FerringM., ClaridgeM., SmithS.A., WilminkT.Routine preoperative vascular ultrasound improves patency and use of arteriovenous fistulas for hemodialysis: a randomized trial.Clin J Am Soc Nephrol.2010; 5(12): 2236–2244.
170.
NursalT.Z., OguzkurtL., TercanF.. Is routine preoperative ultrasonographic mapping for arteriovenous fistula creation necessary in patients with favorable physical examination findings? Results of a randomized controlled trial.World J Surg.2006; 30(6): 1100–1107.
171.
GeorgiadisG.S., CharalampidisD.G., ArgyriouC., GeorgakarakosEl, LazaridesM.K.The Necessity for Routine Pre-operative Ultrasound Mapping Before Arteriovenous Fistula Creation: A Meta-analysis.Eur J Vasc Endovasc Surg.2015; 49(5): 600–605.
CaroliA., ManiniS., AntigaL.. ARCH project Consortium. Validation of a patient-specific hemodynamic computational model for surgical planning of vascular access in hemodialysis patients.Kidney Int.2013; 84(6): 1237–1245.
174.
ZonnebeldN., HubertsW., van LoonM.M., DelhaasT., TordoirJ.H.Preoperative computer simulation for planning of vascular access surgery in hemodialysis patients.J Vasc Access.2017; 18(Suppl. 1): 118–124.
